Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
VC-01
print preview
bookmark
share with colleague
General Information
Company
ViaCyte Inc.
Description
ViaCyte's PEC-01 cells, which are human embryonic stem cells (hESCs)-derived pancreatic progenitor cells, encapsulated in ViaCyte's implantable Encaptra delivery system
Molecular Target
Mechanism of Action
Cell therapy
Latest Stage of Development
Preclinical
Indication
Diabetes
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy